Non-Hodgkin's lymphoma: Present status and future prospects

Thomas M. Habermann

doi:10.3810/hp.1999.12.178

Non-Hodgkin's lymphoma: Present status and future prospects

Thomas M. Habermann

Hematology

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Both management and prognosis vary with the many different varieties of non-Hodgkin's lymphoma. In large-cell disease, age and other risk factors influence prognosis. Relapses may respond to chemotherapy plus autologous bone marrow transplantation. Therapy with antibodies to tumor cells has made its debut, but its role remains unclear.

Original language	English (US)
Pages (from-to)	81-88
Number of pages	8
Journal	Hospital Practice
Volume	34
Issue number	13
DOIs	https://doi.org/10.3810/hp.1999.12.178
State	Published - Dec 15 1999

ASJC Scopus subject areas

General Medicine

Access to Document

10.3810/hp.1999.12.178

Cite this

@article{ba29a2b093064c329a89cd9b1c2c9070,

title = "Non-Hodgkin's lymphoma: Present status and future prospects",

abstract = "Both management and prognosis vary with the many different varieties of non-Hodgkin's lymphoma. In large-cell disease, age and other risk factors influence prognosis. Relapses may respond to chemotherapy plus autologous bone marrow transplantation. Therapy with antibodies to tumor cells has made its debut, but its role remains unclear.",

author = "Habermann, {Thomas M.}",

year = "1999",

month = dec,

day = "15",

doi = "10.3810/hp.1999.12.178",

language = "English (US)",

volume = "34",

pages = "81--88",

journal = "Hospital Practice",

issn = "8750-2836",

publisher = "Taylor and Francis Ltd.",

number = "13",

}

TY - JOUR

T1 - Non-Hodgkin's lymphoma

T2 - Present status and future prospects

AU - Habermann, Thomas M.

PY - 1999/12/15

Y1 - 1999/12/15

N2 - Both management and prognosis vary with the many different varieties of non-Hodgkin's lymphoma. In large-cell disease, age and other risk factors influence prognosis. Relapses may respond to chemotherapy plus autologous bone marrow transplantation. Therapy with antibodies to tumor cells has made its debut, but its role remains unclear.

AB - Both management and prognosis vary with the many different varieties of non-Hodgkin's lymphoma. In large-cell disease, age and other risk factors influence prognosis. Relapses may respond to chemotherapy plus autologous bone marrow transplantation. Therapy with antibodies to tumor cells has made its debut, but its role remains unclear.

UR - http://www.scopus.com/inward/record.url?scp=0033573351&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033573351&partnerID=8YFLogxK

U2 - 10.3810/hp.1999.12.178

DO - 10.3810/hp.1999.12.178

M3 - Article

C2 - 10611900

AN - SCOPUS:0033573351

SN - 8750-2836

VL - 34

SP - 81

EP - 88

JO - Hospital Practice

JF - Hospital Practice

IS - 13

ER -

Non-Hodgkin's lymphoma: Present status and future prospects

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this